U.S. authorizes additional batch of Johnson and Johnson’s COVID-19 vaccine

(Reuters) – The U.S. Food and Drug Administration on Tuesday authorized an additional batch of Johnson and Johnson’s COVID-19 vaccine doses manufactured at a troubled Baltimore facility.

(Reporting by Amruta Khandekar; Editing by Arun Koyyur)